CliffBio
small molecule

ANTARA (MICRONIZED)

FENOFIBRATE

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameANTARA (MICRONIZED)
Active ingredientFENOFIBRATE
Strength87MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2004
Marketing statusDISCN

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.